Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study

Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in medical wards remains unknown.Objectives: To evaluate the effects of intermediate-dose vs. standard-dose prophylactic anticoagul...

Full description

Bibliographic Details
Main Authors: David M. Smadja, Guillaume Bonnet, Nicolas Gendron, Orianne Weizman, Lina Khider, Antonin Trimaille, Tristan Mirault, Charles Fauvel, Jean-Luc Diehl, Delphine Mika, Aurelien Philippe, Théo Pezel, Guillaume Goudot, Willy Sutter, Benjamin Planquette, Victor Waldmann, Olivier Sanchez, Ariel Cohen, Richard Chocron
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Medicine
Subjects:
SARS-CoV-2
anticoagulation
intermediate dose
prophylactic treatment
mortality
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.747527/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.747527/full

Similar Items